• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAWN 试验中的系列观察:梗死演变及其临床影响。

Serial ASPECTS in the DAWN Trial: Infarct Evolution and Clinical Impact.

机构信息

Neurovascular Imaging Research Core, UCLA, Los Angeles, CA (D.S.L., H.S.).

Texas Stroke Institute, Dallas-Fort Worth (P.B., A.J.Y.).

出版信息

Stroke. 2021 Oct;52(10):3318-3324. doi: 10.1161/STROKEAHA.120.033477. Epub 2021 Jul 20.

DOI:10.1161/STROKEAHA.120.033477
PMID:34281376
Abstract

BACKGROUND AND PURPOSE

The impact of baseline ischemia on Alberta Stroke Program Early CT Score (ASPECTS) and evolution over 24 hours may be distinct in late thrombectomy. We analyzed predictors of serial ASPECTS and clinical outcomes in the DAWN trial (Diffusion-Weighted Imaging or CTP Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo).

METHODS

The DAWN Imaging Core Laboratory independently scored ASPECTS at baseline and 24 hours. Descriptive statistics characterized ASPECTS on computed tomography/magnetic resonance imaging at baseline and 24 hours, delineating ASPECTS change over 24 hours.

RESULTS

206 subjects (mean age 70.0±13.7 years; 54.9% (n=113) female; baseline National Institutes of Health Stroke Scale median (interquartile range) 17 (13, 21) were included. Baseline ASPECTS was median (interquartile range) 8.0 (7–8), with 92/205 (44.9%) between 0 and 7 and 113/205 (55.1%) 8 and 10. 24-hour ASPECTS was median 6.0 (4–8), with ASPECTS change or infarct evolution having median −1, ranging from −8 to +2. Multivariable logistic regression showed older age (odds ratio [OR] for 10-year interval, 1.26 [95% CI, 1.02–1.55], P=0.030) and dyslipidemia (OR, 1.84 [95% CI, 1.06–3.19], P=0.031) were independently associated with higher baseline ASPECTS. Higher 24-hour ASPECTS was predicted by endovascular treatment (OR, 2.76 [95% CI, 1.58–4.81], P=0.0004), baseline glucose <150 mg/dL (OR, 2.86 [95% CI, 1.50–5.46], P=0.001), lower baseline National Institutes of Health Stroke Scale (OR, 0.93 [95% CI, 0.89–0.98], P=0.010), and older age (OR for 10-year interval, 1.25 [95% CI, 1.01–1.55], P=0.041). Internal carotid artery lesion location (OR, 0.47 [95% CI, 0.24–0.89], P=0.021) was inversely related to 24-hour ASPECTS. Good clinical outcome (day 90 modified Rankin Scale score 0–2) was predicted by 24-hour ASPECTS (OR, 1.46 [95% CI, 1.08–1.96], P=0.014). Extensive infarct evolution (ASPECTS decrease ≥6) occurred in 14/201 (7.0%). Elevated baseline serum glucose ≥150 mg/dL was a predictor of ASPECTS decrease of ≥4 points (OR, 2.78 [95% CI, 1.21–6.35] P=0.016) as was internal carotid artery occlusion (OR, 2.49 [95% CI, 1.05–5.88]; P=0.038). ASPECTS change was influenced by treatment arm (P=0.001 by Wilcoxon), including 0 ASPECTS change in 42/105 (40.0%) of the endovascular arm and only 20/96 (20.8%) of the medical arm.

CONCLUSIONS

DAWN subjects enrolled with small infarct cores had a broad range of baseline ASPECTS. Twenty-four-hour ASPECTS, strikingly influenced by endovascular therapy, predicted good clinical outcomes.

REGISTRATION

https://www.clinicaltrials.gov; Unique identifier: NCT02142283.

摘要

背景与目的

在晚期取栓中,基线缺血对 Alberta 卒中项目早期 CT 评分(ASPECTS)的影响及其 24 小时的演变可能不同。我们分析了 DAWN 试验(在接受神经介入治疗的觉醒和迟发性卒中患者中,通过弥散加权成像或 CTP 评估与临床不匹配进行的治疗选择)中连续 ASPECTS 和临床结局的预测因素。

方法

DAWN 成像核心实验室独立对基线和 24 小时的 ASPECTS 进行评分。描述性统计分析了 CT 或磁共振成像的基线和 24 小时的 ASPECTS,描述了 24 小时内 ASPECTS 的变化。

结果

206 名受试者(平均年龄 70.0±13.7 岁;54.9%(n=113)为女性;基线国立卫生研究院卒中量表中位数(四分位距)为 17(13,21)。基线 ASPECTS 中位数为 8.0(7-8),92/205(44.9%)为 0-7,113/205(55.1%)为 8-10。24 小时 ASPECTS 中位数为 6.0(4-8),ASPECTS 变化或梗死演变的中位数为-1,范围从-8 到+2。多变量逻辑回归显示,年龄较大(每 10 年间隔的优势比,1.26[95%可信区间,1.02-1.55],P=0.030)和血脂异常(优势比,1.84[95%可信区间,1.06-3.19],P=0.031)与较高的基线 ASPECTS 独立相关。较高的 24 小时 ASPECTS 与血管内治疗(优势比,2.76[95%可信区间,1.58-4.81],P=0.0004)、基线血糖<150mg/dL(优势比,2.86[95%可信区间,1.50-5.46],P=0.001)、较低的基线国立卫生研究院卒中量表(优势比,0.93[95%可信区间,0.89-0.98],P=0.010)和年龄较大(每 10 年间隔的优势比,1.25[95%可信区间,1.01-1.55],P=0.041)有关。颈内动脉病变部位(优势比,0.47[95%可信区间,0.24-0.89],P=0.021)与 24 小时 ASPECTS 呈负相关。良好的临床结局(90 天改良 Rankin 量表评分 0-2)与 24 小时 ASPECTS(优势比,1.46[95%可信区间,1.08-1.96],P=0.014)有关。广泛的梗死演变(ASPECTS 下降≥6)发生在 201 例中的 14 例(7.0%)。基线血清葡萄糖升高≥150mg/dL 是 ASPECTS 下降≥4 分的预测因素(优势比,2.78[95%可信区间,1.21-6.35],P=0.016),颈内动脉闭塞也是如此(优势比,2.49[95%可信区间,1.05-5.88];P=0.038)。ASPECTS 的变化受到治疗臂的影响(Wilcoxon 检验 P=0.001),其中血管内治疗组的 0 变化为 42/105(40.0%),而药物治疗组的仅为 20/96(20.8%)。

结论

在小梗死核心的 DAWN 受试者中,基线 ASPECTS 范围广泛。24 小时 ASPECTS 受血管内治疗的显著影响,预测良好的临床结局。

登记

https://www.clinicaltrials.gov;唯一标识符:NCT02142283。

相似文献

1
Serial ASPECTS in the DAWN Trial: Infarct Evolution and Clinical Impact.DAWN 试验中的系列观察:梗死演变及其临床影响。
Stroke. 2021 Oct;52(10):3318-3324. doi: 10.1161/STROKEAHA.120.033477. Epub 2021 Jul 20.
2
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial.DAWN 试验 6-24 小时后取栓治疗卒中的侧支循环。
Stroke. 2022 Mar;53(3):742-748. doi: 10.1161/STROKEAHA.121.034471. Epub 2021 Nov 3.
3
Serial Alberta Stroke Program early CT score from baseline to 24 hours in Solitaire Flow Restoration with the Intention for Thrombectomy study: a novel surrogate end point for revascularization in acute stroke.在 Solitaire Flow Restoration 伴取栓治疗意图的急性卒中研究中,基线至 24 小时的 Alberta 卒中项目早期 CT 评分:急性卒中血管再通的新替代终点。
Stroke. 2014 Mar;45(3):723-7. doi: 10.1161/STROKEAHA.113.003914. Epub 2014 Feb 13.
4
Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial.影响 DAWN 试验血运重建和结果的围手术期和技术因素及患者特征。
Stroke. 2020 Jan;51(1):247-253. doi: 10.1161/STROKEAHA.119.026437. Epub 2019 Nov 20.
5
Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods.采用 Trevo(DAWN)试验方法对接受神经介入治疗的觉醒后和迟发脑卒中患者进行临床不匹配的弥散加权成像或计算机断层灌注评估。
Int J Stroke. 2017 Aug;12(6):641-652. doi: 10.1177/1747493017710341. Epub 2017 Jun 1.
6
Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.非对比增强计算机断层扫描阿尔伯塔省卒中项目早期 CT 评分可能会改变 DAWN 中的动脉内治疗效果。
Stroke. 2019 Sep;50(9):2404-2412. doi: 10.1161/STROKEAHA.118.024583. Epub 2019 Jul 26.
7
Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.取栓治疗与患者亚组卒中结局的相关性:DEFUSE 3 随机临床试验的二次分析。
JAMA Neurol. 2019 Apr 1;76(4):447-453. doi: 10.1001/jamaneurol.2018.4587.
8
Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).在SWIFT PRIME试验(以Solitaire FR取栓术作为急性缺血性卒中主要血管内治疗手段)中,磁共振成像与计算机断层扫描灌注成像选择的患者中,支架取栓术的疗效对比
Stroke. 2017 Jun;48(6):1560-1566. doi: 10.1161/STROKEAHA.117.016669. Epub 2017 May 2.
9
Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core.在大脑中动脉M1段闭塞且梗死核心有限的患者中,临床扩散不匹配比平均通过时间-扩散加权成像不匹配更能区分梗死灶扩大。
J Neurointerv Surg. 2017 Feb;9(2):127-130. doi: 10.1136/neurintsurg-2014-011602. Epub 2016 Mar 8.
10
Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial.血管内血栓切除术的获益与发病模式相关:DAWN 试验的二次分析。
Stroke. 2019 Nov;50(11):3141-3146. doi: 10.1161/STROKEAHA.119.025795. Epub 2019 Oct 1.

引用本文的文献

1
Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke: The POST-UK Randomized Clinical Trial.急性缺血性卒中血管内再灌注后动脉内注射尿激酶:POST-UK随机临床试验
JAMA. 2025 Feb 18;333(7):589-598. doi: 10.1001/jama.2024.23480.
2
[Imaging-based patient selection for mechanical thrombectomy based on time since symptom onset].基于症状发作时间的机械取栓术影像学患者选择
Nervenarzt. 2021 Aug;92(8):733-743. doi: 10.1007/s00115-021-01121-0. Epub 2021 May 10.